Article Information
History
- June 9, 2021.
Article Versions
- Version 1 (June 6, 2021 - 11:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Eva Muthamia*,1,
- Samuel Mungai*,1,
- Mary Mungai2,
- Gama Bandawe3,
- Firdausi Qadri4,9,
- Zannat Kawser4,
- Shahin Lockman6,8,
- Louise C. Ivers7,13,
- David Walt8,10,
- Sara Suliman6,11,12,
- Matilu Mwau2 and
- Jesse Gitaka1,14,#
- 1Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya
- 2Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
- 3Biological Sciences Department, Academy of Sciences, Malawi University of Science and Technology, Thyolo, Malawi
- 4Institute for developing Science and Health initiatives (ideSHi), Dhaka, Bangladesh
- 5Mass General Brigham Center for COVID Innovation, Boston, MA
- 6Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital, Boston MA, USA
- 7Division of Infectious Diseases, Brigham and Women’s Hospital, Boston MA, USA
- 8Harvard T.H. Chan School of Public Health, Boston MA, USA
- 9International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
- 10Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
- 11Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
- 12Department of Global Health and Social Medicine, Harvard Medical School, Boston MA, USA
- 13Division of Infectious Diseases, Massachusetts General Hospital, Boston MA, USA
- 14Centre for Malaria Elimination, Mount Kenya University, Thika, Kenya
- ↵#corresponding author: Jesse Gitaka, jgitaka{at}mku.ac.ke
↵* These authors contributed equally.
Posted June 09, 2021.
ASSESSMENT OF PERFORMANCE AND IMPLEMENTATION CHARACTERISTICS OF RAPID POINT OF CARE SARS-CoV-2 ANTIGEN TESTING
